About Xavo
Software as a Service (SaaS) to accelerate the Research and Development process in Pharma and Biopharma
Contact
XAVO USA
Xavo USA Inc.
One Boston Place, Suite 2600
Boston, MA 02108, USA
XAVO GERMANY
Xavo Software AG
Spinnereistrasse 7
D-95445 Bayreuth
XAVO SWITZERLAND
Xavo Systems AG
Dornacherstrasse 8
CH-4053 Basel
About Xavo
Software as a Service (SaaS) to accelerate the Research and Development process in Pharma and Biopharma
Contact
XAVO USA
Xavo USA Inc.
One Boston Place, Suite 2600
Boston, MA 02108, USA
XAVO GERMANY
Xavo Software AG
Spinnereistrasse 7
D-95445 Bayreuth
XAVO SWITZERLAND
Xavo Systems AG
Dornacherstrasse 8
CH-4053 Basel
All Xavo entities are ISO 9001 certified.
Copyright © 2022 Xavo Software AG | All Rights Reserved
Chief Executive Officer
Reda Bensaid is an accomplished Strategic Executive and Advisor with over 20 years of experience in the B2B software space. Reda has a track record of delivering sustainable revenue growth by driving strategic industry focus, winning go-to-market strategies and organizational alignment. He joined Xavo as Chief Executive Officer in February of 2020 to refine the group’s strategic direction and transform its execution practices.
Prior to joining Xavo, he was the General Manager of Omneo, a SaaS cloud-based big data analytics software for supply chain product quality management, also named a cool vendor by Gartner in 2014. He also held the position of VP of Corporate and Industry Strategy at Camstar Systems, an MES company that got acquired by Siemens in 2014.
Reda holds a BS in Management Information Systems from the University of South Florida and received post-graduate Executive education from the Harvard Business School.
Executive Vice President Marketing & Sales
Ralf Sonnefeld is an experienced executive and transformational leader with a career of 25+ years in various managerial roles in the B2B software and automation industry. He has led international and diverse teams to profitable and sustained growth in global markets. He joined Xavo in 2016 with the aim to build a successful software product business, serving today as Xavo’s Executive Vice President Marketing & Sales.
Prior to joining Xavo, he worked for Siemens where he gained broad international experience when serving as the CEO of IndX Software Inc. based in the U.S., and subsequently, as a sales and operations leader in their industrial software business with a global P&L responsibility out of the company’s global headquarters in Italy and Germany. Ralf also served as Chairman, Vice Chairman and Board Member at Large for MESA International, a global industry not-for-profit organization between 2006 and 2015.
He holds a Master of Science degree in Electrical Engineering from Friedrich-Alexander-University Erlangen-Nuremberg and received additional manager training in business strategy and business administration from Babson College.
Vice President Industry Strategy
Randy Hice is a globally recognized leader in the field of life sciences laboratory automation with a particular focus on complex Biopharma R&D and manufacturing operations, multi-site harmonization, and Business Process Improvement. In 2021 he joined Xavo as Vice President for Industry Strategy where he analyzes and communicates the constantly-evolving needs of the Biopharma R&D market to Xavo Product Management and Development teams.
Prior to joining Xavo, Randy served as an Industry Principal Director for Accenture where he was responsible for Digital Laboratory and Digital Chemistry, Manufacturing, and Controls (CMC) business development. He also served as Manager of Global Strategy for Abbott Informatics where he examined portfolio opportunities in markets outside the United States.
As Chief Technology Officer for Cedrus Investments, Hong Kong, Randy was responsible for analyzing emerging biotechnology companies specializing in CRISPR/CAS9 gene editing, CAR T Cell therapies, and monoclonal/polyclonal antibodies development. He also designed the Stem Cell Research Center for a clinic in the Shanghai Free Trade Zone.
Randy was a monthly columnist for Scientific Computing Magazine for more than 20 years and served on their Editorial Board. He has published more than 200 articles addressing all aspects of laboratory automation.
Randy holds a university degree in Organic Chemistry from Western Michigan University where he received the 2017 Alumni Achievement Award for Chemistry.
Vice President Product Management
Thomas Frech is a recognized thought leader in the Laboratory IT, Automation and Biopharma industry with over 20 years of professional experience. He joined Xavo in 2011 as Product Manager Lab Logistics and moved on to become a Director, responsible for Xavo’s Life Science business in 2017. He currently serves as the Vice President of Product Management where he is responsible for the implementation of Xavo’s mission to provide commercial off-the-shelf software, built to accelerate the Research and Development process in Pharma and Biopharma.
Prior to joining Xavo, he held positions as an Application Architect and IT Analyst at Novartis Switzerland where he gained broad experience in designing and developing lab IT and automation systems. Since 2010, Thomas has been serving the Association Consortium Standardization in Lab Automation (SiLA) as Vice President, Treasurer and Board Member. He also represents Xavo as a Corporate Member at the Society for Laboratory Automation and Screening (SLAS).
Thomas holds a university degree in Electrical Engineering as well as a Master of Advanced Studies degree in Information Technology from the University of Applied Sciences and Arts Northwestern Switzerland. He is also a Certified Professional for Requirements Engineering (CPRE).
Chief Technology Officer
Zak Merzouki is an accomplished B2B R&D executive with a history of successfully leading global organizations, responsible for the engineering and delivery of mission-critical commercial off-the-shelf enterprise software products including SaaS applications. He has a strong technological background in SaaS, Industrial IoT, Big Data Analytics, Machine Learning, Mobile and CI/CD Technologies. Zak joined Xavo in April of 2020 as a Chief Technology Officer.
Prior to joining Xavo, Zak served as Vice President of Software Engineering of Omneo, a SaaS cloud-based big data analytics software for supply chain product quality management, also named a cool vendor by Gartner in 2014. He was also Vice President R&D at Camstar Systems, an MES company that got acquired by Siemens in 2014.
Zak holds a Master of Science degree in Electronics Engineering and Applied Physics from University Lille as well as an Engineering Degree in Engineering Physics from Institut Polytechnique de Grenoble where he also participated in a Doctoral Program in Electrical Engineering and Computational Physics. He is also the author of several technical publications.
VP Value Realization
Rami Lokas has over 20 years of software industry experience in various capacities including research & development, architecture, design, engineering and consulting. He joined Xavo in April 2021 and currently serves as its Vice President of Value Realization where his responsibilities include the management of all project deliveries and the confirmation of value delivered.
As a previous Director of Research & Development, his team introduced two market–disrupting technologies, one of which earned a cool vendor award by Gartner in 2014 and a Global Frost & Sullivan award for Customer Value Excellence in 2016. In his role, he also established a successful offshore outsource model and managed large globally distributed teams.
Prior to joining Xavo, Rami served as Senior Director of Software Engineering at Siemens, working with 16 global teams and products to standardize and ensure compliance with best practices, quality, and testing.
Rami holds a Bachelor of Mechanical Engineering from Georgia Institute of Technology and a Masters of Science from MIT. Rami has been a guest speaker at both, Dell World and O’Reilly’s Strata and Hadoop World Conference.
General Manager Promexx
Uwe Schey is an experienced executive and operations expert with a successful track record of nearly 30 years in various managerial positions in the IT and automation industry. He has experience in leading cross-functional teams in multi-year IT programs for large international companies. He joined Xavo in 2003 as Project Manager and joined the Executive team in 2005 with the aim to make Xavo an International brand by creating the highest value for its global customers. He is serving today as the General Manager for the Promexx business.
Prior to joining Xavo, he worked in the Manufacturing IT realm for leading companies in the Automotive and Consumer Goods industry. For British-American Tobacco he led the IT Services organization in their worldwide largest Manufacturing facility at that time with the responsibility to ensure zero downtime operation of all critical IT systems.
Uwe holds a Master degree in Computer Science from Friedrich-Alexander-University Erlangen-Nuremberg.
Executive Vice President Finance, Admin & HR
Detlef Riedel is an accomplished entrepreneur and executive with over 40 years of experience in the software development space. He founded Xavo Germany in 2000 and led the company to profitable and sustained growth in the global operations industry. In 2009 Detlef founded Xavo Switzerland and started LabLogistics, a software product initiative for pharmaceutical research and development. He is a recognized expert in software product development and serves today as Xavo’s Executive Vice President Finance, Admin & HR.
Prior to founding Xavo, he held several project management positions at German Federal Railways and British American Tobacco where he focused on large software projects in the fields of ERP and MES. He also was a founding member of the Swiss Life Science Consortium Standardization in Lab Automation (SiLA).
Detlef holds a Master’s degree in Computer Science from Technical University Dresden.
Reda Bensaid, President and CEO of Xavo, is talking on the ‘Leaders of B2B’ podcast about what it takes for Xavo to deliver differentiated value to its customers in Biopharma R&D.
To listen to the full interview, select one of the following options:
